1.
Rocha RA da S, Silva N de O, Cetlin RS, Fabiola Dach. Observational analysis of 12 years-experience with OnabotulinumtoxinA in the treatment of chronic migraine treated in a tertiary headache center. Headache Med [Internet]. 2023 Dec. 20 [cited 2024 Nov. 21];14(Supplement):131. Available from: https://headachemedicine.com.br/index.php/hm/article/view/992